NPAF Co-Hosts Briefing on Oral Chemotherapy Agents |
|
On January 21st, National Patient Advocate Foundation joined with national oncology providers and advocates to brief congressional staff on the value of oral chemotherapeutic agents in cancer care. NPAF advocate Jere Carpentier from San Jose, California described her cancer journey along with other panelists. After being diagnosed with advanced colon cancer, Jere was unable to access a prescribed oral chemotherapy drug because her insurer denied coverage and told her she would have to pay for it out-of-pocket which would have cost $2,000 for a 14-day supply, a sum she could not afford.
As Jere stated, "Having equal coverage of oral chemotherapy, in my situation, would have made my hazardous leak and emergency room visit non-existent as I could have been much more comfortable and safe taking the pill form." |